Timothy Leach

937 total citations
22 papers, 564 citations indexed

About

Timothy Leach is a scholar working on Genetics, Epidemiology and Immunology. According to data from OpenAlex, Timothy Leach has authored 22 papers receiving a total of 564 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Genetics, 8 papers in Epidemiology and 5 papers in Immunology. Recurrent topics in Timothy Leach's work include Inflammatory Bowel Disease (9 papers), Microscopic Colitis (7 papers) and Helicobacter pylori-related gastroenterology studies (3 papers). Timothy Leach is often cited by papers focused on Inflammatory Bowel Disease (9 papers), Microscopic Colitis (7 papers) and Helicobacter pylori-related gastroenterology studies (3 papers). Timothy Leach collaborates with scholars based in United States, Canada and Netherlands. Timothy Leach's co-authors include Irving H. Fox, Asit Parikh, Brian G. Feagan, Catherine Scholz, Serap Sankoh, Tim Wyant, Diane R. Mould, Terry Ponich, Leonard E. Klebanoff and Jing Xu and has published in prestigious journals such as Blood, Scientific Reports and International Journal of Hydrogen Energy.

In The Last Decade

Timothy Leach

22 papers receiving 548 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Timothy Leach United States 10 289 258 175 86 64 22 564
Kirtan Patel United States 9 199 0.7× 145 0.6× 48 0.3× 158 1.8× 41 0.6× 34 481
Philip Griffin United Kingdom 20 27 0.1× 161 0.6× 159 0.9× 70 0.8× 28 0.4× 30 1.0k
Pierre Wauters Belgium 10 33 0.1× 41 0.2× 200 1.1× 6 0.1× 57 0.9× 14 408
Rusheng Zhang China 11 83 0.3× 106 0.4× 36 0.2× 31 0.4× 61 1.0× 35 395
Manjil Chatterji United States 14 85 0.3× 181 0.7× 93 0.5× 89 1.0× 43 0.7× 22 549
Rishi Patel United States 13 114 0.4× 158 0.6× 40 0.2× 57 0.7× 124 1.9× 102 857
Mark D.P. Davis United States 16 65 0.2× 179 0.7× 64 0.4× 73 0.8× 98 1.5× 29 775
Sedef Şahin Türkiye 15 110 0.4× 165 0.6× 157 0.9× 39 0.5× 274 4.3× 56 834
José Carlos Cardoso Portugal 18 99 0.3× 468 1.8× 53 0.3× 107 1.2× 141 2.2× 122 971
Hiroshi Fujiwara Japan 13 60 0.2× 117 0.5× 228 1.3× 160 1.9× 95 1.5× 34 716

Countries citing papers authored by Timothy Leach

Since Specialization
Citations

This map shows the geographic impact of Timothy Leach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timothy Leach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timothy Leach more than expected).

Fields of papers citing papers by Timothy Leach

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Timothy Leach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timothy Leach. The network helps show where Timothy Leach may publish in the future.

Co-authorship network of co-authors of Timothy Leach

This figure shows the co-authorship network connecting the top 25 collaborators of Timothy Leach. A scholar is included among the top collaborators of Timothy Leach based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Timothy Leach. Timothy Leach is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Leach, Timothy, et al.. (2024). Exploring variations in the weight, size and shape of liquid hydrogen tanks for zero-emission fuel-cell vessels. International Journal of Hydrogen Energy. 80. 1441–1465. 7 indexed citations
2.
Leach, Timothy, Uma Gandhi, Kristina Stumpf, et al.. (2023). Development of a novel air–liquid interface airway tissue equivalent model for in vitro respiratory modeling studies. Scientific Reports. 13(1). 10137–10137. 31 indexed citations
3.
Leach, Timothy, et al.. (2022). Organoid Technologies for SARS-CoV-2 Research. Current Stem Cell Reports. 8(4). 151–163. 2 indexed citations
4.
Klebanoff, Leonard E., et al.. (2021). Comparative study of a hybrid research vessel utilizing batteries or hydrogen fuel cells. International Journal of Hydrogen Energy. 46(76). 38051–38072. 38 indexed citations
5.
Klebanoff, Leonard E., et al.. (2020). Feasibility of the Zero-V: A zero-emissions hydrogen fuel-cell coastal research vessel. International Journal of Hydrogen Energy. 45(46). 25328–25343. 54 indexed citations
6.
Leach, Timothy, et al.. (2017). Safety, Pharmacokinetics, and Immunogenicity of Obiltoxaximab After Intramuscular Administration to Healthy Humans. Clinical Pharmacology in Drug Development. 7(6). 652–660. 15 indexed citations
7.
Rosario, Maria, Timothy Wyant, Timothy Leach, et al.. (2016). Vedolizumab Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability Following Administration of a Single, Ascending, Intravenous Dose to Healthy Volunteers. Clinical Drug Investigation. 36(11). 913–923. 38 indexed citations
8.
Leach, Timothy, et al.. (2016). Pharmacokinetics and Tolerability of Obiltoxaximab: A Report of 5 Healthy Volunteer Studies. Clinical Therapeutics. 38(9). 2083–2097.e7. 17 indexed citations
9.
McAuliffe, Megan, Stephan Lanes, Timothy Leach, et al.. (2015). Occurrence of adverse events among patients with inflammatory bowel disease in the HealthCore Integrated Research Database. Current Medical Research and Opinion. 31(9). 1655–1664. 32 indexed citations
10.
Parikh, Asit, Irving H. Fox, Timothy Leach, et al.. (2013). Long-term Clinical Experience with Vedolizumab in Patients with Inflammatory Bowel Disease. Inflammatory Bowel Diseases. 19(8). 1691–1699. 70 indexed citations
11.
12.
Parikh, Asit, Timothy Leach, Tim Wyant, et al.. (2011). Vedolizumab for the Treatment of Active Ulcerative Colitis: A Randomized Controlled Phase 2 Dose-ranging Study. Inflammatory Bowel Diseases. 18(8). 1470–1479. 182 indexed citations
13.
Parikh, A., et al.. (2011). Long-term clinical experience with vedolizumab for the treatment of inflammatory bowel disease. Inflammatory Bowel Diseases. 17(suppl_1). S56–S56. 4 indexed citations
14.
Parikh, Asit, Timothy Leach, Jing Xu, & Brian G. Feagan. (2011). Long-term clinical experience with Vedolizumab in patients with mild to moderate Ulcerative Colitis. Inflammatory Bowel Diseases. 17. S23–S23. 2 indexed citations
15.
16.
Parikh, A., Eric R. Fedyk, Vivek J. Kadambi, et al.. (2009). P130 - Gastrointestinal selectivity of vedolizumab (MLN0002), a humanized monoclonal antibody to α 4β 7 integrin. Journal of Crohn s and Colitis. 3(1). S62–S62. 1 indexed citations
17.
Feagan, Brian G., Timothy Leach, Catherine Milch, A. Parikh, & Irving H. Fox. (2009). Emerging Safety Profile of Vedolizumab: A novel, selective Integrin Inhibitor for the treatment of IBD. Inflammatory Bowel Diseases. 15. S12–S12. 4 indexed citations
18.
Parikh, A., Eric R. Fedyk, Timothy Wyant, et al.. (2008). Gastrointestinal selectivity of vedolizumab (MLN0002), a humanized monoclonal antibody to the alpha4beta7 integrin. Inflammatory Bowel Diseases. 14. S18–S18. 4 indexed citations
19.
Leach, Timothy, et al.. (2005). Principal Axes for Structural Fatigue. SNAME Maritime Convention. 113. 466–491. 2 indexed citations
20.
Rogers, Bruce L. & Timothy Leach. (2004). New approaches to Clostridium difficile colitis therapy. Drug Discovery Today Therapeutic Strategies. 1(4). 513–517. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kirtan Patel Breakdown of academic impact, for papers by Philip Griffin Breakdown of academic impact, for papers by Pierre Wauters Breakdown of academic impact, for papers by Rusheng Zhang Breakdown of academic impact, for papers by Manjil Chatterji Breakdown of academic impact, for papers by Rishi Patel Breakdown of academic impact, for papers by Mark D.P. Davis Breakdown of academic impact, for papers by Sedef Şahin Breakdown of academic impact, for papers by José Carlos Cardoso Breakdown of academic impact, for papers by Hiroshi Fujiwara
Rankless by CCL
2026